Home » Topics » Regulatory

Regulatory
RSS

Raloxifene indicated for excess NPY associated disorders

July 26, 1996

Duloxetine claimed for new indication

July 26, 1996

Fujisawa claims tacrolimus as allergic conjunctivitus treatment

July 26, 1996

Ciclosporin demonstrates efficacy and safety as an antimetabolite

July 26, 1996

InSite Vision and Bausch & Lomb announce alliance regarding glaucoma drug

July 26, 1996

New formulation of CGP-41251

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

Chlorhexidine gluconate effective in reducing incidence of nosocomial respiratory tract infections

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.